Login to Your Account



Rimonabant Redux?

New Drug Stays Out of Brain, Fights Metabolic Disorders

By Anette Breindl
Science Editor

Monday, August 13, 2012

The typical headache for drug developers is a drug that won't cross the blood-brain barrier. But researchers from the National Institutes of Health and Jenrin Discovery Inc. hope to find success by preventing that crossing.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription